5 Temporal Lobe Epilepsy Clinical Trials in Atlanta, GA (2026)

Q: How do I join a clinical trial in Atlanta?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you.

Recruiting Temporal Lobe Epilepsy Studies in Atlanta

NCT06876649Recruiting

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after completion of clinical studies evaluating pirtobrutinib....

Atlanta, GAPHASE4787 participantsEli Lilly and Company

View Study Details

NCT07580183Recruiting

Spatial Scene Recognition Memory in Epilepsy Surgery

This study investigates the anatomical and physiological basis of spatial scene recognition memory in patients with temporal lobe epilepsy and temporal lobe lesions. Standard neuropsychological tests ...

Atlanta, GANA620 participantsUniversity of California, Davis

View Study Details

NCT06055439Recruiting

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

The goal of this clinical trial is to evaluate CHM-2101, an autologous CDH17 CAR T-cell therapy for the treatment of advanced gastrointestinal (GI) cancers that are relapsed or refractory to at least ...

Atlanta, GAPHASE1135 participantsChimeric Therapeutics

View Study Details

NCT06049680Recruiting

Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

Evaluate the risk of developing EFAD and/or PNAC in adult and pediatric patients 1 month of age and older, who are anticipated to need 8 weeks or longer of parenteral nutrition treatment with SMOFlipi...

Atlanta, GAPHASE4100 participantsFresenius Kabi

View Study Details

NCT07003295Recruiting

Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy

This phase II trial tests the safety and side effects of glofitamab and obinutuzumab and how well they work in treating patients with mantle cell lymphoma that has come back after a period of improvem...

Atlanta, GAPHASE220 participantsNational Cancer Institute (NCI)

View Study Details

About Temporal Lobe Epilepsy Clinical Trials in Atlanta

Temporal lobe epilepsy is the most common form of focal epilepsy, with seizures originating in the temporal lobe of the brain. It can cause unusual sensations, memory problems, and altered consciousness. Treatment includes antiseizure medications and surgery for drug-resistant cases.

There are currently 5 temporal lobe epilepsy clinical trials recruiting participants in Atlanta, GA. These studies are seeking a combined 1,662 participants. Research is being sponsored by Eli Lilly and Company, University of California, Davis, Chimeric Therapeutics and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Temporal Lobe Epilepsy Clinical Trials in Atlanta — FAQ

Are there temporal lobe epilepsy clinical trials in Atlanta?

Yes, there are 5 temporal lobe epilepsy clinical trials currently recruiting in Atlanta, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Atlanta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.

Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.

What temporal lobe epilepsy treatments are being tested?

The 5 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for temporal lobe epilepsy.

Data updated October 15, 2026 from ClinicalTrials.gov